Meet the Under-35s: Biotech's Latest Darlings
Ah, the annual parade of youthful geniuses from the MIT Technology Review. This year, they've spotlighted nine bright sparks in biotechnology, claiming they're reshaping the future. Let's take a closer look at five of these wunderkinds and their so-called revolutionary work.
Paschal Kija: The Saviour of Maternal Health?
Paschal Kija has developed the Mkanda Salama, a supposedly affordable device to treat postpartum hemorrhage. Sure, it's a noble cause, especially for sub-Saharan Africa, but let's not forget the countless 'affordable' solutions that never see the light of day beyond the prototype stage.
Xiao Yang: The Brain Electrode Magician
Xiao Yang is designing ultra-small, flexible brain electrodes inspired by kirigami. These are meant to reduce brain tissue damage. Sounds impressive, right? But let's remember, the road from lab to hospital is littered with failed innovations that promised the same.
Sarah Grandinette: The Gene Editing Trailblazer
Sarah Grandinette co-developed a personalized gene-editing therapy for a rare genetic disorder. Personalized medicine is the buzzword of the decade, but how many of these therapies actually make it past clinical trials?
Yuancheng (Ryan) Lu: The Visionary of Vision
Yuancheng Lu has concocted a cell reprogramming therapy to reverse vision loss. It's in clinical trials, but let's not pop the champagne just yet. The history of biotech is full of therapies that dazzled in trials but fizzled in reality.
Samuel King: The AI Bacteriophage Designer
Samuel King used a generative AI model to design new bacteriophages. These tiny viruses could potentially be used in drug manufacturing or pollution control. AI-designed life forms? Sounds like the plot of a sci-fi movie, doesn't it?